// App-Quantinova.ai

e15587 : Contribution of eukaryotic translation initiation factor 3B to the pathogenesis of hepatocellular carcinoma via targeting EGFR and ZAK.

Researchers

Presenter

  • Jian-Feng Zheng

Principal Investigators

  • Xiao-he Jiang

  • Yu Chen

  • Li-li Cai

  • Xiao-zhong Wang

  • Wu-hua Guo

  • Ji-xiang Zhang

Medical Centers

  • Second Affiliated Hospital, Nanchang University, Nanchang, Nanchang, AL, China

  • Second Affiliated Hospital, Nanchang University, Nanchang, Nanchang, AL, China

  • Second Affiliated Hospital, Nanchang University, Nanchang, Nanchang, AL, China

  • Second Affiliated Hospital, Nanchang University, Nanchang, Nanchang, AL, China

  • 2.Department of Gastroenterology, Second Affiliated Hospital, Nanchang University, Nanchang, Nanchang, China

  • Jiangxi Provincial Key Laboratory of Molecular Medicine, Nanchang, Nanchang, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Solid malignancies

Biomarkers

  • Epidermal growth factor receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved